Ancora Advisors’s Guardant Health GH Stock Holding History

Ancora Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-600	Closed	-$21.5K	–	1796
2023 Q2	$21.5K	Sell	600 -25	-4%	-$718	﹤0.01%	1117
2023 Q1	$14.7K	Buy	625 +25	+4%	+$714	﹤0.01%	1204
2022 Q4	$16K	Hold	600	–	–	﹤0.01%	1238
2022 Q3	$32K	Hold	600	–	–	﹤0.01%	1207
2022 Q2	$24K	Hold	600	–	–	﹤0.01%	1389
2022 Q1	$40K	Sell	600 -150	-20%	-$10.3K	﹤0.01%	1334
2021 Q4	$75K	Buy	750 +150	+25%	+$15.5K	﹤0.01%	1116
2021 Q3	$75K	Hold	600	–	–	﹤0.01%	1062
2021 Q2	$75K	Hold	600	–	–	﹤0.01%	975
2021 Q1	$92K	Hold	600	–	–	﹤0.01%	902
2020 Q4	$77K	Hold	600	–	–	﹤0.01%	798
2020 Q3	$67K	Hold	600	–	–	﹤0.01%	798
2020 Q2	$49K	Hold	600	–	–	﹤0.01%	824
2020 Q1	$42K	Hold	600	–	–	﹤0.01%	923
2019 Q4	$47K	Buy	+600	New	+$43.2K	﹤0.01%	902

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ancora Advisors's GH Position: Q3 2023 in Review

Ancora Advisors sold out of Guardant Health (GH) in Q3 2023, closing a stake of 600 shares — an estimated $21.5K sold.

Ancora Advisors first reported a position in GH in Q4 2019 and held it in 15 quarters. The position peaked at $92K in Q1 2021. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

Ancora Advisors reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
Ancora Advisors sold 600 Guardant Health shares in Q3 2023, an estimated $21.5K.
Ancora Advisors first reported a position in Guardant Health in Q4 2019 and held it in 15 quarters.
Ancora Advisors's Guardant Health position peaked at $92K in Q1 2021.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Ancora Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.